share_log
Reuters ·  Nov 8 06:07
Ventyx Biosciences Inc: Cash Balance of $274.8M as of September 30, 2024 Expected to Fund Operations Into at Least H2 2026
Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment